Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1983-02-11
1984-04-03
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544291, A61K 31505, C07D40304
Patent
active
044407696
ABSTRACT:
4-amino-6,7-dimethoxy-2-(4-phenylalkanoylpiperazin-1-yl) quinazolines having .alpha..sub.1 -adrenergic receptor antagonistic activity. These compounds are useful in the treatment of hypertension.
REFERENCES:
patent: 3511836 (1970-05-01), Hess
patent: 3635979 (1972-01-01), Hess
patent: 3663706 (1972-05-01), Hess
patent: 4092315 (1978-05-01), Bianco
The Journal of Biological Chemistry, vol. 257, No. 24, Issue of 12/25, pp. 15174-15181, 1982.
Proc. Natl. Acad. Sci., U.S.A., vol. 79, pp. 2186-2190, Apr. 1982, Biochemistry.
The Journal of Biological Chemistry, vol. 257, No. 20, Issue of Oct. 25, pp. 12332-12340, 12341-12350, 1982, U.S.A.
Federation Proceedings, Mar. 10, 1982, vol. 41, No. 5, Abstract 7064.
DeBernardis John F.
Winn Martin
Abbott Laboratories
Katz Martin L.
Lee Mary C.
Shelton Dennis K.
Turnipseed James H.
LandOfFree
2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-667110